No Data
No Data
Guangdong Transtek Medical Electronics (300562.SZ): The holding subsidiary has obtained acceptance of the renewal of the medical instrument production license.
Guangdong Transtek Medical Electronics (300562.SZ) announced on September 23 that its holding subsidiary, Shenzhen Ruikanghongye Technology Development Co., Ltd. (referred to as "Ruikanghongye"), recently received the "Acceptance Certificate" issued by the Guangdong Provincial Drug Administration, learning that the application for the extension of the medical device production license by Ruikanghongye has been accepted. The company is positioned as a "medical-grade remote health monitoring equipment and service provider," always placing a high emphasis on the compliance of medical device standards, and promoting the development of the full range of products towards medical-grade orientation. The extension of the aforementioned medical device production license is based on the needs of the company's business operations, conducive to further solidifying the foundation.
Guangdong Transtek Medical Electronics (300562.SZ): has repurchased 1.10% of the shares.
LeXin Medical (300562.SZ) announced on September 2nd that as of August 31, 2024, the company has repurchased a total of 2,377,200 shares of the company through the repurchase dedicated securities account in a centralized bidding manner, accounting for 1.10% of the current total share capital of the company (the current total share capital of the company is 216,901,188 shares). On July 11, 2024, the company transferred 1,500,000 shares of the repurchase account to the "Guangdong Transtek Medical Electronics Co., Ltd. - 2024 Employee Shareholding Plan" by means of non-trading transfer, for the purpose of
A Piece Of The Puzzle Missing From Guangdong Transtek Medical Electronics Co., Ltd's (SZSE:300562) 28% Share Price Climb
The medical instrument registration application for the wrist electronic blood pressure monitor applied for by Guangdong Transtek Medical Electronics (300562.SZ) has been accepted.
Guangdong Transtek Medical Electronics (300562.SZ) announced that the company recently received the "Acceptance Certificate" issued by the Guangdong Provincial Drug Administration for the clinical trial application of its new pharmaceutical product.
Guangdong Transtek Medical Electronics: Half-year report for the year 2024.
Guangdong Transtek Medical Electronics: Summary of Half-Year Report in 2024.
No Data
No Data